A business in context
DNTH research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-17 | CARR EDWARD | M · Exercise / conversion | Common Stock | 20000.0 | 17.88 |
| 2026-09-17 | CARR EDWARD | S · Sale | Common Stock | 7928.0 | 100.43 |
| 2026-09-17 | CARR EDWARD | S · Sale | Common Stock | 6771.0 | 101.37 |
| 2026-09-17 | CARR EDWARD | S · Sale | Common Stock | 3501.0 | 102.39 |
| 2026-09-17 | CARR EDWARD | S · Sale | Common Stock | 700.0 | 104.39 |
| 2026-09-17 | CARR EDWARD | S · Sale | Common Stock | 1100.0 | 103.2 |
| 2026-09-17 | CARR EDWARD | M · Exercise / conversion | Stock Option (Right to Buy) | 20000.0 | 0.0 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Common Stock | 7500.0 | 17.88 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Common Stock | 6249.0 | 21.77 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Common Stock | 9375.0 | 22.07 |
| 2026-09-01 | Randhawa Simrat | S · Sale | Common Stock | 2600.0 | 105.19 |
| 2026-09-01 | Randhawa Simrat | S · Sale | Common Stock | 7215.0 | 106.25 |
| 2026-09-01 | Randhawa Simrat | S · Sale | Common Stock | 13309.0 | 106.74 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Stock Option (Right to Buy) | 9375.0 | 0.0 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Stock Option (Right to Buy) | 6249.0 | 0.0 |
| 2026-09-01 | Randhawa Simrat | M · Exercise / conversion | Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-08-19 | Read Simon | M · Exercise / conversion | Common Stock | 2778.0 | 18.36 |
| 2026-08-19 | Read Simon | S · Sale | Common Stock | 2778.0 | 117.55 |
| 2026-08-19 | Read Simon | M · Exercise / conversion | Stock Option (Right to Buy) | 2778.0 | 0.0 |
| 2026-08-13 | Veness Adam M | M · Exercise / conversion | Common Stock | 15000.0 | 18.17 |
| 2026-08-13 | Veness Adam M | M · Exercise / conversion | Stock Option (Right to Buy) | 15000.0 | 0.0 |
| 2026-08-10 | McGeorge Anne | S · Sale | Common Stock | 1000.0 | 110.64 |
| 2026-08-10 | McGeorge Anne | S · Sale | Common Stock | 700.0 | 111.41 |
| 2026-08-10 | McGeorge Anne | S · Sale | Common Stock | 1800.0 | 109.3 |
| 2026-08-10 | McGeorge Anne | S · Sale | Common Stock | 2800.0 | 108.38 |
| 2026-08-10 | McGeorge Anne | S · Sale | Common Stock | 1450.0 | 107.58 |
| 2026-08-10 | McGeorge Anne | M · Exercise / conversion | Common Stock | 6500.0 | 11.2 |
| 2026-08-10 | McGeorge Anne | M · Exercise / conversion | Common Stock | 1250.0 | 19.36 |
| 2026-08-10 | McGeorge Anne | M · Exercise / conversion | Stock Option (Right to Buy) | 1250.0 | 0.0 |
| 2026-08-10 | McGeorge Anne | M · Exercise / conversion | Stock Option (Right to Buy) | 6500.0 | 0.0 |
| 2026-08-10 | Veness Adam M | M · Exercise / conversion | Common Stock | 16167.0 | 17.88 |
| 2026-08-10 | Veness Adam M | S · Sale | Common Stock | 16167.0 | 110.38 |
| 2026-08-10 | Veness Adam M | M · Exercise / conversion | Stock Option (Right to Buy) | 16167.0 | 0.0 |
| 2026-08-10 | Read Simon | M · Exercise / conversion | Common Stock | 2777.0 | 18.36 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 70.0 | 107.11 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 737.0 | 108.17 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 831.0 | 108.95 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 272.0 | 109.96 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 397.0 | 111.77 |
| 2026-08-10 | Read Simon | S · Sale | Common Stock | 470.0 | 111.05 |
| 2026-08-10 | Read Simon | M · Exercise / conversion | Stock Option (Right to Buy) | 2777.0 | 0.0 |
| 2026-08-07 | Veness Adam M | S · Sale | Common Stock | 616.0 | 111.18 |
| 2026-08-07 | Veness Adam M | S · Sale | Common Stock | 3217.0 | 110.61 |
| 2026-08-07 | Veness Adam M | M · Exercise / conversion | Common Stock | 3833.0 | 17.88 |
| 2026-08-07 | Veness Adam M | M · Exercise / conversion | Stock Option (Right to Buy) | 3833.0 | 0.0 |
| 2026-08-07 | Garcia Marino | S · Sale | Common Stock | 2373.0 | 109.1 |
| 2026-08-07 | Garcia Marino | S · Sale | Common Stock | 2536.0 | 110.02 |
| 2026-08-07 | Garcia Marino | S · Sale | Common Stock | 800.0 | 110.76 |
| 2026-08-07 | Garcia Marino | S · Sale | Common Stock | 104091.0 | 107.96 |
| 2026-08-07 | Garcia Marino | S · Sale | Common Stock | 23907.0 | 108.05 |
Identity & relationships
SEC issuer · 0001690585Dianthus Therapeutics, Inc. /DE/
Search names and former names
View Wikidata identity and references ↗
- Magenta Therapeutics · alias · wikidata
- Magenta Therapeutics, Inc. · former SEC name · 2016-11-23 to 2023-09-08
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $6.24M | $6.70M |
| 2023-12-31 | $2.83M | $3.12M |
| 2019-12-31 | $0 | $0 |
| 2018-12-31 | $0 | $0 |
| 2017-12-31 | $0 | $0 |